MAPT and neurodegenerative disease: Recently, it has been shown that the protein tau has increased levels in CSF of SCA2 patients [37], and the protein neurofilament light (NfL) chain is suitable to indicate axonal degeneration in many neurodegenerative diseases, including SCA2 [34, 65].